Bekanntmachung • Mar 17
DYD Co.,LTD., Annual General Meeting, Mar 31, 2026 DYD Co.,LTD., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 30, dongsong-ro, deogyang-gu, gyeonggi-do, goyang South Korea New Risk • Mar 01
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risks Shareholders have been diluted in the past year (21% increase in shares outstanding). Market cap is less than US$100m (₩54.1b market cap, or US$37.6m). Bekanntmachung • Feb 05
DYD Co.,LTD. announced that it has received KRW 6.000000708 billion in funding from Oulange Trade Limited On February 4, 2026. DYD Co.,LTD. announces that it has closed the transaction. Bekanntmachung • Jan 23
DYD Co.,LTD. announced that it expects to receive KRW 4.000001193 billion in funding from Oulange Trade Limited DYD Co.,LTD announced a private placement to issue 3,244,121 common shares at a price of KRW 1,233 for aggregate gross proceeds of KRW 4,000,001,193 on January 21, 2026. The transaction has been approved by the board of directors and is expected to close on March 31, 2026. The shares issued in the transaction will be held for a 1 year lockup period. The transaction will include participation from Oulange Trade Limited. New Risk • Dec 24
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 5x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Share price has been highly volatile over the past 3 months (29% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩28.6b market cap, or US$19.7m). New Risk • Nov 07
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₩1.25b (US$857.0k) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Shareholders have been substantially diluted in the past year (59% increase in shares outstanding). Market cap is less than US$10m (₩1.25b market cap, or US$857.0k). Minor Risk Share price has been volatile over the past 3 months (10% average weekly change). New Risk • Jul 15
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Shareholders have been substantially diluted in the past year (59% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩54.4b market cap, or US$39.3m). Bekanntmachung • Feb 28
DYD Co.,LTD., Annual General Meeting, Mar 31, 2025 DYD Co.,LTD., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 30, dongsong-ro, deogyang-gu, gyeonggi-do, goyang South Korea Bekanntmachung • Nov 07
DYD Co.,LTD. announced that it expects to receive KRW 12.000001389 billion in funding from Reverse Aging Holdings Co., Ltd. and other investors DYD Co.,LTD. announced a private placement to issue 20,725,391 common shares at an issue price of KRW 579 per share for the gross proceeds of KRW 12,000,001,389 on November 5, 2024. The transaction will include participation from new and returning investors Reverse Aging Holdings Co., Ltd. 12,089,811 shares, ELF No.1 Fund 4,317,790 shares and ELF No.2 Fund 4,317,790 shares. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on December 5, 2024. New Risk • Aug 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩22.8b market cap, or US$16.9m). New Risk • Jul 12
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩58.9b market cap, or US$42.8m). New Risk • Apr 30
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 14% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risks Shareholders have been diluted in the past year (14% increase in shares outstanding). Market cap is less than US$100m (₩45.7b market cap, or US$33.1m). New Risk • Feb 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2021 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Shareholders have been diluted in the past year (42% increase in shares outstanding). Market cap is less than US$100m (₩42.9b market cap, or US$32.3m). Bekanntmachung • May 31
DYD Co.,LTD. announced that it has received KRW 999.999704 million in funding On May 30, 2023, DYD Co.,LTD. closed the transaction. Bekanntmachung • May 24
DYD Co.,LTD. announced that it expects to receive KRW 999.99926 million in funding DYD Co.,LTD. announced a private placement of 1,053,740 shares at a price of KRW 949 per share for a gross proceeds of KRW 999,999,260 on May 22, 2023. The transaction will include participation from individual investor, Lee, Il-jun. The company issued shares through third party allocation method. The transaction has been approved by the board of directors. The transaction is expected to close on May 30, 2023. Bekanntmachung • Feb 15
DYD Co.,LTD. announced that it has received KRW 10 billion in funding from Well Biotech Co., Ltd. On February 14, 2023, DYD Co.,LTD. closed the transaction. The bonds will mature on February 14, 2026. The conversion period is from February 14, 2024 to January 14, 2026. Bekanntmachung • Feb 10
DYD Co.,LTD. announced that it expects to receive KRW 10 billion in funding from Well Biotech Co., Ltd. DYD Co.,LTD. announced a private placement of 5th series unsecured privately placed convertible bonds with bearer interest for gross proceeds of KRW 10,000,000,000 on February 8, 2023. The transaction will include participation from Well Biotech Co., Ltd. The bond carry coupon rate of 5% and have yield to maturity of 10%. The bonds will mature on February 10, 2026. The bonds will be 100% convertible into 5,757,052 common shares of the company, representing 13.55% of the total number of shares at a fixed conversion price of KRW 1,737 per share. The conversion period is from February 10, 2024 to January 10, 2026. The transaction has a subscription date of February 10, 2023 and payment date of February 10, 2023. The transaction has been approved by the board of directors of the company. Bekanntmachung • Apr 29
Jaanh Cosmetics,Inc. announced that it has received KRW 40 billion in funding from Meritz Securities Co., Ltd., Investment Arm On April 28, 2021, Jaanh Cosmetics,Inc. (KOSDAQ:A219550) closed the transaction. Bekanntmachung • Apr 28
Jaanh Cosmetics,Inc. announced that it expects to receive KRW 40 billion in funding from Meritz Securities Co., Ltd., Investment Arm Jaanh Cosmetics,Inc. (KOSDAQ:A219550) announced a private placement of series 4 non-guaranteed private equity convertible bonds with bearer interest for gross proceeds of KRW 40,000,000,000 on April 27, 2021. The transaction will include participation from Meritz Securities Co., Ltd., Investment Arm. The convertible debentures have a coupon rate of 5.5% and maturity interest rate of 5.5% with debentures maturity date on April 28, 2026. The debentures are 100% convertible into 41,152,263 shares at a conversion price of KRW 972 for 34.02% stake in the company. The conversion period starts on April 29, 2022 and ends on March 28, 2026. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is April 27, 2021 and payment date is April 28, 2021. Is New 90 Day High Low • Feb 09
New 90-day low: ₩1,055 The company is down 5.0% from its price of ₩1,115 on 11 November 2020. The South Korean market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Retail Distributors industry, which is up 9.0% over the same period. Is New 90 Day High Low • Nov 30
New 90-day high: ₩1,470 The company is up 24% from its price of ₩1,185 on 01 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Retail Distributors industry, which is up 17% over the same period. 